Dr Alina Wilkowska reports grants from Medical University of Gdańsk, during the conduct of the study and has received research support from Angelini, Biogen, Eli Lilly and Company, Janssen-Cilag, Lundbeck, Polpharma, Sanofi and Valeant. Dr Adam Włodarczyk has received research support from Actavis, Eli Lilly, Minerva Neurosciences, Sunovion Pharmaceuticals, KCR, Janssen, Otsuka, Apodemus, Cortexyme, and Acadia. Dr Maria Gałuszko-Węgielnik has received research support from Janssen, Servier, Alkermes, KCR, Lilly, Biogen, and Celon. Dr Mariusz S Wiglusz has received research support from Acadia, Apodemus, Alkermes, Auspex Pharmaceuticals, Cephalon, Ferrier, Forest Laboratories, Gedeon Richter, GWPharma-ceuticals, Janssen, Lundbeck, Orion, Otsuka, Servier, Speakers Bureau: Lundbeck, Servier. Prof. Wiesław J Cubała has received research support from Acadia, Actavis, Alkermes, Allergan, Angelini, Auspex, Biogen, Bristol-Myers Squibb, Cephalon, Cortexyme, Eli Lilly, Ferrier, Forest Laboratories, Gedeon Richter, GW Pharmaceuticals, Janssen, KCR, Lundbeck, Minerva, NeuroCo, NIH, Orion, Otsuka, Sanofi, and Ser-vier; he has served on speakers bureaus for Adamed, Angelini, AstraZeneca, Bristol-Myers Squibb, Celon, GlaxoSmithKline, Janssen, Krka, Lekam, Lundbeck, Novartis, Orion, Pfizer, Polfa Tarchomin, Sanofi, Servier, and Zentiva; and he has served as a consultant for GW Pharmaceuticals, Janssen, KCR, Quintiles, and Roche. The authors report no other conflicts of interest in this work.
PubMed
